The Department of Health and Social Care reported 209 medicines shortages in 2019, over half of which occurred for three months or more, according to monthly updates sent to NHS providers.
Pharmacists can expect to see new FP10 prescription forms from the end of January 2020.
A pilot of a national system for reporting unexpected or severe illicit drug reactions has been stopped because of a lack of use by healthcare professionals.
Patients are being encouraged to “take the drama out of minor illnesses” by visiting their pharmacist, as part of a movie poster-inspired campaign to encourage greater use of community pharmacies.
The UK’s communications regulator, Ofcom, has received more than 2,300 complaints following comments made about pharmacists on ITV’s This Morning.
Pharmacists could be asked to advise patients on drinking and smoking under NICE proposalsSubscription
Community pharmacists could be asked to strike up a conversation with patients about their general wellbeing, to encourage them to stop smoking, cut down on drinking and/or lose weight.
Increasing long-chain omega-3 intake probably has little or no effect in preventing depression or anxiety symptoms, according to a systematic review and meta-analysis in The British Journal of Psychiatry.
Pharmacist-led interventions in GP practices can successfully reduce risk factors for cardiovascular events, a systematic review and meta-analysis published in the British Journal of Clinical Pharmacology has suggested.
Women with asthma who experience exacerbations during pregnancy are more likely to have birth complications than women with well-controlled asthma, a study published in the European Respiratory Journal has suggested.
Opioids offer only small benefits in terms of pain and function in osteoarthritis and do not improve quality of life or depression, research presented at the 2019 American College of Rheumatology annual meeting has suggested.
Individuals treated for opioid dependency who also take benzodiazepines are almost three times more likely to die from an overdose, research published in PLoS Medicine has suggested.
Off-label fluoxetine may help overweight and obese people to lose weight, but the evidence supporting this is limited, the authors of a Cochrane review have concluded.